Literature DB >> 10841898

Fentanyl, a upsilon-opioid receptor agonist, phase shifts the hamster circadian pacemaker.

J H Meijer1, A C Ruijs, H Albus, B van de Geest, H Duindam, A H Zwinderman, A Dahan.   

Abstract

The phase-shifting effects of the mu-opioid receptor agonist fentanyl on the circadian timing system were investigated in the hamster. Fentanyl injections during the mid-subjective day induced phase advances of the hamsters' wheel-running activity rhythm. The shifts were not accompanied by an increase in locomotor activity but instead a decrease of activity was often observed. A dose-response curve indicated that with increasing dosage, the response probability increased, while the magnitude of the induced shift remained stable. The present data suggest that there is some role for opioid regulation of the circadian system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841898     DOI: 10.1016/s0006-8993(00)02317-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Acute morphine affects the rat circadian clock via rhythms of phosphorylated ERK1/2 and GSK3β kinases and Per1 expression in the rat suprachiasmatic nucleus.

Authors:  Dominika Pačesová; Barbora Volfová; Kateřina Červená; Lucie Hejnová; Jiří Novotný; Zdeňka Bendová
Journal:  Br J Pharmacol       Date:  2015-05-11       Impact factor: 8.739

2.  Morphine Accumulates in the Retina Following Chronic Systemic Administration.

Authors:  Nikolas Bergum; Casey-Tyler Berezin; Gregory Dooley; Jozsef Vigh
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-25

3.  Opioid chronopharmacology: influence of timing of infusion on fentanyl's analgesic efficacy in healthy human volunteers.

Authors:  Merel Boom; Joost Grefkens; Eveline van Dorp; Erik Olofsen; Gertjan Lourenssen; Leon Aarts; Albert Dahan; Elise Sarton
Journal:  J Pain Res       Date:  2010-09-21       Impact factor: 3.133

4.  Molecular rhythm alterations in prefrontal cortex and nucleus accumbens associated with opioid use disorder.

Authors:  Xiangning Xue; Wei Zong; Jill R Glausier; Sam-Moon Kim; Micah A Shelton; BaDoi N Phan; Chaitanya Srinivasan; Andreas R Pfenning; George C Tseng; David A Lewis; Marianne L Seney; Ryan W Logan
Journal:  Transl Psychiatry       Date:  2022-03-26       Impact factor: 7.989

Review 5.  A retinal contribution to opioid-induced sleep disorders?

Authors:  Nikolas Bergum; Casey-Tyler Berezin; Jozsef Vigh
Journal:  Front Neurosci       Date:  2022-08-05       Impact factor: 5.152

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.